Aethlon Med

AEMD NASDAQ
0.3700
+0.0220
+6.32%
Closed 16:00 06/24 EDT
Open
0.3703
Prev Close
0.3480
High
0.3703
Low
0.3490
Volume
45.09K
Avg Vol (3M)
167.31K
52 Week High
1.740
52 Week Low
0.3000
% Turnover
0.24%
Market Cap
7.02M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Aethlon Med AEMD stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Aethlon Medical, Inc. is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities. The Company's lead product is the Aethlon Hemopurifier, which is a device that selectively targets the elimination of circulating viruses and tumor-secreted exosomes that promote cancer progression. The Aethlon Hemopurifier sheds glycoproteins to treat infectious viral pathogens. In oncology indications, the Hemopurifier targets the removal of circulating exosomes, which are released to promote cancer progression and to seed the spread of metastasis. Through its subsidiary, Exosome Sciences, Inc. (Exosome), the Company is also developing exosome-based product candidates to diagnose and monitor neurological disorders and cancer.
MORE >

Recently

Name
Price
%Change